rs587783765
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 4P and 6B. PM1PM5BP4_ModerateBS2
The NM_000252.3(MTM1):c.1234A>C(p.Ile412Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000414 in 1,208,237 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I412V) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000252.3 missense
Scores
Clinical Significance
Conservation
Publications
- X-linked myotubular myopathyInheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen, Myriad Women’s Health, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MTM1 | NM_000252.3 | c.1234A>C | p.Ile412Leu | missense_variant | Exon 11 of 15 | ENST00000370396.7 | NP_000243.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000267 AC: 3AN: 112221Hom.: 0 Cov.: 23 show subpopulations
GnomAD2 exomes AF: 0.00000549 AC: 1AN: 182221 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000182 AC: 2AN: 1096016Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 361410 show subpopulations
GnomAD4 genome AF: 0.0000267 AC: 3AN: 112221Hom.: 0 Cov.: 23 AF XY: 0.0000582 AC XY: 2AN XY: 34371 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.1234A>C (p.I412L) alteration is located in exon 11 (coding exon 10) of the MTM1 gene. This alteration results from a A to C substitution at nucleotide position 1234, causing the isoleucine (I) at amino acid position 412 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Severe X-linked myotubular myopathy Uncertain:1
This sequence change replaces isoleucine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 412 of the MTM1 protein (p.Ile412Leu). This variant is present in population databases (no rsID available, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with MTM1-related conditions. Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt MTM1 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at